MBOT Straddle Strategy
MBOT (Microbot Medical Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development.
MBOT (Microbot Medical Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $79.1M, a beta of 1.05 versus the broader market, a 52-week range of 1.6-4.67, average daily share volume of 1.2M, a public-listing history dating back to 1992, approximately 43 full-time employees. These structural characteristics shape how MBOT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.05 places MBOT roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a straddle on MBOT?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
MBOT snapshot
As of August 14, 2026, spot at $1.52, ATM IV 36.60%, IV rank 4.75%, expected move 10.49%. The straddle on MBOT below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this straddle structure on MBOT specifically: MBOT IV at 36.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a MBOT straddle, with a market-implied 1-standard-deviation move of approximately 10.49% (roughly $0.16 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MBOT expiries trade a higher absolute premium for lower per-day decay. Position sizing on MBOT should anchor to the underlying notional of $1.52 per share and to the trader's directional view on MBOT stock.
MBOT straddle setup
The MBOT straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MBOT at $1.52 on that close, the first option leg uses a $1.52 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MBOT chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MBOT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.52 | N/A |
| Buy 1 | Put | $1.52 | N/A |
MBOT straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
MBOT straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on MBOT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on MBOT
Straddles on MBOT are pure-volatility plays that profit from large moves in either direction; traders typically buy MBOT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
MBOT thesis for this straddle
The market-implied 1-standard-deviation range for MBOT extends from approximately $1.36 on the downside to $1.68 on the upside. A MBOT long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current MBOT IV rank near 4.75% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MBOT at 36.60%. As a Healthcare name, MBOT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MBOT-specific events.
MBOT straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MBOT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MBOT alongside the broader basket even when MBOT-specific fundamentals are unchanged. Always rebuild the position from current MBOT chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on MBOT?
- A straddle on MBOT is the straddle strategy applied to MBOT (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With MBOT stock at $1.52 on the most recent close, the strikes shown on this page are snapped to the nearest listed MBOT chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are MBOT straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the MBOT straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 36.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MBOT straddle?
- The breakeven for the MBOT straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The MBOT market-implied 1-standard-deviation expected move in the same options snapshot is approximately 10.49%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on MBOT?
- Straddles on MBOT are pure-volatility plays that profit from large moves in either direction; traders typically buy MBOT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current MBOT implied volatility affect this straddle?
- MBOT ATM IV is at 36.60% with IV rank near 4.75%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.